HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

MARUWA Profits Fell In Q2 FY2025, But A Record-Breaking 2026 Is Still Expected

Operating Profit Dips 15%, Yet MARUWA Forecasts a Record-Breaking Year. Here's What's Really Happening Introduction: When...
SGX-LISTED COMPANIES

AIMS APAC REIT Forward-Thinking 1H FY2026

4 Surprising Strategies Fueling This Real Estate Giant’s Success Introduction: The Hidden Dynamics of Real...
SGX-LISTED COMPANIES

SIA Engineering Signals Rapid Expansion After FY2025/26 Half-Year Results

3 Hidden Truths in an Aviation Giant's Financials 1. The Real Profit Isn't from Operations—It's...
SGX-LISTED COMPANIES

Captii Limited Posts Lower Q3 2025 Revenue But Delivers Strong Surge In Profit

Lower Revenue, Better Results? 4 Surprising Insights Hidden in This Tech Company's Financials Introduction: It’s easy...
SGX-LISTED COMPANIES

MSM International’s Profit Jumps 264% In Half-Year 2026

Profits Surged 264% While Margins Fell: 5 Surprising Insights from MSM International's Financials MSM International's...
SGX-LISTED COMPANIES

Why NetLink NBN’s Profit Fell 10% But Cash Distributions Rose In H1 FY26

NetLink's Profits Fell 10%, So Why Are Investor Payouts Rising? 3 Surprising Insights from...
SGX-LISTED COMPANIES

The AI Boom Is Powering A Surge In Core Components For Murata Manufacturing In Q2 2025

4 Surprising Insights from a Tech Giant’s Billion-Dollar Earnings Beat In a global climate marked...
SGX-LISTED COMPANIES

Find Out How Great Eastern’s Sales Are Down, But Long-Term Profit Is Up In Q3FY2025

3 Surprising Truths Buried in Great Eastern's Latest Financials Introduction: More Than Meets the Eye A...
SGX-LISTED COMPANIES

Revenue Crisis For Miyoshi Limited In FY2025

Here Are 5 Surprising Truths We Found In Miyoshi Limited's FY2025 Financial Report. We dove...
SGX-LISTED COMPANIES

Why Lion Asiapac’s S$7 Million Loss In Q1 2025 Isn’t As Bad As It Seems

How a S$7.3 Million Loss Can Actually Be Good News: A Deep Dive into...
SGX-LISTED COMPANIES

Sheng Siong Stores Are Thriving In Q3 FY2025

Your Grocery Bill is Just the Beginning: 5 Surprising Strategies We Learned From Sheng...
SGX-LISTED COMPANIES

Operations Win Big — But Wilmar International Still Took A Major Loss In Q3 2025

How to Earn $357.2 Million and Lose $347.7 Million at the Same Time: 4...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...